ArticleMedComm2026

Adjuvant Atezolizumab for Stage III Deficient Mismatch Repair Colon Cancer-Its Impact on Clinical Practice.

Yun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.